HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
KYN 54
structure given in first source; a novel synthesized retinoid; potential chemopreventive agent for intestinal neoplasm
Also Known As:
5-hydroxy-4-(2-phenyl-(E)-ethenyl)-2(5H)-furanone; KYN-54; KYN54; 2(5H)-Furanone, 5-hydroxy-4-(2-phenylethenyl)-, (E)-
Networked:
7
relevant articles (
1
outcomes,
1
trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Organic Chemicals: 133
Hydrocarbons: 1713
Terpenes: 1461
Carotenoids: 4095
Retinoids: 5957
KYN 54: 7
Cyclic Hydrocarbons: 97
Alicyclic Hydrocarbons: 1
Cycloparaffins: 6
Cyclohexanes: 3
Cyclohexenes: 4
Carotenoids: 4095
Retinoids: 5957
KYN 54: 7
Acyclic Hydrocarbons
Alkenes: 265
Polyenes: 164
Carotenoids: 4095
Retinoids: 5957
KYN 54: 7
Lactones: 1549
4-Butyrolactone: 81
KYN 54: 7
Biological Factors: 2472
Biological Pigments: 1
Carotenoids: 4095
Retinoids: 5957
KYN 54: 7
Heterocyclic Compounds: 198
1-Ring Heterocyclic Compounds
Furans: 85
4-Butyrolactone: 81
KYN 54: 7
Related Diseases
1.
Carcinoma (Carcinomatosis)
09/01/1995 - "
Feeding of KYN-54 during either initiation or post-initiation phase caused a significant reduction in the frequency of tongue carcinoma (48-71% reduction, P < 0.05) and such chemopreventive efficacy was dose-related.
"
2.
Carcinogenesis
06/08/1995 - "
These results provide further evidence that KYN-54 could be a chemopreventive agent against rat colon carcinogenesis.
"
01/29/1999 - "
In contrast, the multiplicity of lung tumors of mice receiving KYN-54 during the post-initiation phase was significantly larger than of the animals with NNK alone (P < 0.05), showing that KYN-54 has a promoting effect on pulmonary carcinogenesis in mice.
"
09/01/1995 - "
These results indicate that the novel synthesized retinoidal butenolide KYN-54 inhibits oral carcinogenesis initiated with 4-NQO and such inhibition may be related to suppression of cell proliferation.
"
09/01/1995 - "
Inhibition of 4-nitroquinoline-1-oxide-induced rat oral carcinogenesis by dietary exposure of a new retinoidal butenolide, KYN-54, during the initiation and post-initiation phases.
"
01/01/1997 - "
A novel synthesized retinoidal butenolide, KYN-54, which suppresses large bowel as well as tongue carcinogenesis could be a useful agent for prevention of digestive organ cancers.
"
3.
Neoplasms (Cancer)
04/01/1995 - "
These results suggest that KYN-54 might be a promising chemopreventive agent for intestinal neoplasia.
"
04/01/1995 - "
KYN-54 fed group especially, tumor incidence and multiplicity in the entire intestine were lower compared with the AOM alone group (P < 0.005 and P < 0.05 respectively).
"
04/01/1995 - "
Compared with the AOM alone group, KYN-54 at both doses reduced the incidence and multiplicity of tumors in entire intestine (small and large intestines).
"
01/29/1999 - "
In contrast, the multiplicity of lung tumors of mice receiving KYN-54 during the post-initiation phase was significantly larger than of the animals with NNK alone (P < 0.05), showing that KYN-54 has a promoting effect on pulmonary carcinogenesis in mice.
"
01/01/1997 - "
A novel synthesized retinoidal butenolide, KYN-54, which suppresses large bowel as well as tongue carcinogenesis could be a useful agent for prevention of digestive organ cancers.
"
4.
Colorectal Neoplasms (Colorectal Cancer)
09/01/1997 - "
These results indicate that chemopreventive agents for large bowel carcinogenesis, i.e., KYN-54, MMTS, CA, and piroxicam, are not only able to prevent the development of ACF, but also can regress ACF, which are regarded as precursor lesions of colorectal cancer.
"
5.
Mouth Neoplasms (Oral Cancer)
09/01/1995 - "
At 7 weeks of age, all animals except those treated with KYN-54 alone and those in a control group were given 4-NQO (20 p.p.m.) in the drinking water for 8 weeks to induce oral neoplasms.
"
Related Drugs and Biologics
1.
butenolide
2.
Azoxymethane
3.
Drinking Water
4.
4-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide)
5.
Retinoids
6.
Piroxicam (Feldene)
7.
methyl methanethiosulfonate (MMTS)
Related Therapies and Procedures
1.
Chemoprevention